OakChart

Amesite Inc

AMSTTechnology·Software - Application·USA·Nano·NASD·Nov 12 • 3:59 PM ET

0.48-0.02 (-3.82%)
2026-11-13 13:19 CET
Market cap
$3.14M
Revenue, TTM
0.36 USD m
Net income, TTM
-3.10 USD m
Free cash flow, TTM
-2.15 USD m
EPS diluted, TTM
-0.63
Price / earnings
-
Compare

Price

AMST against its 20, 50 and 200-day averages
Terms2050200
Patternshover a marker to name it
RS 00.501.001.502.002.5074.6M149.2MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26AMSTclose 0.4820-day 0.5950-day 0.83200-day 1.260.48

84.3% under the 52-week high of 3.05 on 12 Nov 2025. 52-week low 0.46 on 10 Nov 2026. Last 15 sessions, 40.0% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Setup. RS line 0
CANSLIM 0 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%; Average Volume: Over 200K — not on the tape: EPS Growth This Year: High (>25%)
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); Return on Equity: Over +15% — not on the tape: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%)
Quality 2 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%) — not on the tape: P/E: Under 25
Value 2 of 4 — fails: Return on Equity: Over +15% — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 0 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K

Profile

AMST
52-week range, 1% of the way up
0.463.05

Amesite, Inc. is a technology company, which engages in the development and marketing of B2C and B2B AI-driven solutions for the healthcare sector. It provides tools and direct connection with working nurses and caregivers through its brand, NurseMagic. The company was founded by Ann Marie Sastry on November 14, 2017 and is headquartered in Detroit, MI.

Employees6
IPOSep 25, 2020
Beta1.10
ATR, 14d0.05
Rel volume0.00
Short float0.64%
Insider own32.94%
Inst own5.99%

Snapshot

6 groups

Valuation

Index-
Market Cap$3.14M
Enterprise Value0.84M
Income-3.10M
Sales0.36M
Book / share0.41
Cash / share0.35
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees6
IPOSep 25, 2020

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales8.72
Price / book1.18
Price / cash1.37
Price / free cash flow-
Value / cash profit-
Value / sales2.33
Quick Ratio6.42
Current Ratio6.42
Debt / equity0.00
Long-term debt / equity0.00
Options and shortNo / Yes

Earnings

Earnings / share-0.63
Earnings next year-
Earnings next quarter-
Earnings this year-
Earnings next year-
Earnings growth, 5 years-
Past earnings growth28.03% 37.84%
Past sales growth-24.42% -11.57%
Earnings vs last year43.14%
Sales vs last year230.24%
Earnings vs last quarter11.18%
Sales vs last quarter41.86%
Earnings-
Surprise0.00% 0.00%

Ownership

Insiders own32.94%
Insider trades24.03%
Institutions own5.99%
Institution trades-0.94%
Return on assets-101.06%
Return on equity-114.83%
Return on capital-116.66%
Gross Margin23.95%
Operating margin-861.65%
Profit Margin-848.69%
20-day average-19.11%
50-day average-42.25%
200-day average-61.95%

Technical

Shares out6.55M
Shares floating4.39M
Short / float0.64%
Short ratio0.31
Short interest0.03M
52-week high3.05 -84.3%
52-week low0.46 +4.1%
Volatility10.61% 9.52%
Average range0.05
Strength index20.56
Market sensitivity1.10
Relative volume0.00
Avg Volume91.75K
Volume0

Performance

Perf Week-10.93%
Perf Month-43.18%
Perf Quarter-50.77%
Perf Half Y-42.39%
Perf YTD-74.67%
Perf Year-83.44%
Perf 3Y-77.72%
Perf 5Y-97.17%
Perf 10Y-
Recommendation-
Target Price-
Prev Close0.48
Price0.48
Change %0.00%

Analyst ratings

latest 1 of 1
DateActionAnalystRating changeTargetImplied
Dec 28, 2020InitiatedThe Benchmark CompanySpeculative Buy$7+1,362.3%

Peers

Mkt cap
TickerCompanyMkt cap
DCBODocebo Inc810.38M
NTCLNetClass Technology Inc0.42M
NRDYNerdy Inc75.11M
YXTYxt.Com Group Holding Ltd ADR7.02M
FUSEFusemachines Inc10.41M
HITHealth In Tech Inc34.96M
DUOLDuolingo Inc7.42B
COURCoursera Inc903.75M
JZJianzhi Education Technology Group Co Ltd ADR2.41M
GOTUGaotu Techedu Inc ADR307.75M

Insider trading

2 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Sastry Ann MarieCHIEF EXECUTIVE OFFICERApr 28 '26Buy1.44174,216250,0001,049,647May 18 04:15 PM
Parmer GeorgeDirectorApr 28 '26Buy1.44243,902349,999566,962May 18 04:15 PM

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.79B

News

latest 14 of 200
  • Amesite Announces New Sales Win Under NurseMagic Minimum Enterprise Pricing Model (GlobeNewswire)
  • Amesite Rips 250% On Its Largest AI Healthcare Deployment (GuruFocus.com) +120.07%
  • Amesite shares skyrocket after landing largest enterprise client to date (AMST) (InvestorsHub)
  • Amesite's NurseMagic Wins 2,700-Census Home Care Enterprise Customer (GlobeNewswire)
  • Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -6.67% +8.16%
  • Amesite Announces Insider-Led Private Placement Priced at a Premium to Market (GlobeNewswire)
  • Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -33.54%
  • Amesite Announces Withdrawal of Registration Statement on Form S-1 (GlobeNewswire)
  • Amesite Executes Trading Partner Agreement Enabling Secure Connectivity with Leading Homecare Technology Platform (GlobeNewswire) +6.36%
  • Amesite's NurseMagic Named Finalist for Nurse.org "Best of Nursing: AI Nursing Tool" Award (GlobeNewswire) -6.21%
  • Amesite introduces AI-native EMR system, NurseMagic EMR (Hospital Management) -13.53%
  • Amesite Accelerates Growth With Launch of AI-Native NurseMagic EMR (GlobeNewswire) +17.18%
  • Amesite Announces 69% QoQ Revenue Increase in Q2 2026 and Product Plans for Coming Months (GlobeNewswire)
  • Amesite Reports 63% Revenue Growth from NurseMagic Enterprise; Announces Launch of AI-Powered Government Form-Fill Automation to Reduce Reporting Burden (GlobeNewswire) +44.40%

Quarterly earnings

2021Q1 EPS -3.720. Sales 0.11
PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2021Q1ended 2020-09-302020-12-24-3.720--2.9980.11-EPS - · sales ---Open +0.64% vs SPY +0.14%. Close +1.28% vs SPY +0.39%

Annual earnings

2022FY EPS -0.960 matched -0.960. Sales 1.95 matched 1.95

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2022FY-0.960-0.960-4.6721.951.95-

Quarterly results

2026Q4 revenue 0.08, from 0.06 a year earlier. Operating margin -1,313%, from -1,433% a year earlier
Revenue, USD millions
0.1102025Q1 revenue 0.0125Q12025Q2 revenue 0.0125Q22025Q3 revenue 0.0325Q32025Q4 revenue 0.0625Q42026Q1 revenue 0.0926Q12026Q2 revenue 0.1126Q22026Q3 revenue 0.0826Q32026Q4 revenue 0.0826Q4
Operating margin
0.00-11,3002025Q1 operating margin -9,300%25Q12025Q2 operating margin -11,300%25Q22025Q3 operating margin -2,300%25Q32025Q4 operating margin -1,433%25Q42026Q1 operating margin -733.33%26Q12026Q2 operating margin -681.82%26Q22026Q3 operating margin -850%26Q32026Q4 operating margin -1,313%26Q4

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type.

No estimate revisions.

Estimate history

Annual
Metric201820192020202120222023202420252026
EPS per share-0.899-3.141-3.083-6.759-4.672-1.682-1.732-1.026-0.627
Sales USD millions000111000
Shares million shares111223357
Quarterly
MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
EPS per share-0.465-0.335-0.402-0.164-0.202-0.141-0.16-0.147-0.18
Sales USD millions000000000
Shares million shares333555557

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2026FY6/30/20262025FY6/30/20252024FY6/30/20242023FY6/30/20232022FY6/30/20222021FY6/30/20212020FY6/30/20202019FY6/30/2019
Total Revenue0.360.36+227.3%0.11-35.3%0.17-80.0%0.85+21.4%0.70+4.5%0.67+1016.7%0.06+500.0%0.01
Cost of Goods Sold Incl. D&A0.280.28-34.9%0.43-18.9%0.53-22.1%0.68-22.7%0.88---
Gross Profit0.090.09-0.32-0.37-331.3%0.16-0.18---
Selling, General and Administrative Excl. Other3.233.23-1.5%3.28-22.1%4.21-4.1%4.39-50.6%8.88+12.4%7.90+118.2%3.62-5.5%3.83
Research and Development0.360.36+28.6%0.28-50.9%0.57-34.5%0.87-60.6%2.21+43.5%1.54+14.1%1.35+800.0%0.15
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-3.14-3.14-3.60-4.58-4.22-9.06-7.97-4.08-3.97
Interest Expense0.000.000.000.000.00-100.0%0.01-99.7%3.61+3181.8%0.110.00
Unusual Expense0.000.00-100.0%0.090.000.000.000.000.00-
Net Income Before Taxes-3.10-3.10-3.62-4.40-4.15-9.06-11.59-4.17-3.94
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-3.10-3.10-3.62-4.40-4.15-9.06-11.59-4.17-3.94
Net Income From Continuing Operations-3.10-3.10-3.62-4.40-4.15-9.06-11.59-4.17-3.94
Net Income-3.10-3.10-3.62-4.40-4.15-9.06-11.59-4.17-3.94
EPS (Recurring) per share-0.53-0.63-1.01-1.73-1.68-4.67-6.76-3.08-3.14
EPS (Basic, Before Extraordinaries) per share-0.63-0.63-1.03-1.73-1.68-4.67-6.76-3.08-3.14
EPS (Diluted) per share-0.63-0.63-1.03-1.73-1.68-4.67-6.76-3.08-3.14
EBITDA-2.87-2.87-3.17-4.05-3.54-8.18-7.22-3.56-3.81
Non-Operating Income (Expense)0.050.05-37.5%0.08-55.6%0.18+157.1%0.07+600.0%0.010.00-100.0%0.02-33.3%0.03
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.270.27+17.4%0.23-72.3%0.83+361.1%0.18-87.5%1.44+63.6%0.88+57.1%0.56-8.2%0.61
Price To Sales Ratio ratio21.1918.0085.8645.7110.5515.3683.86--
Gross Margin %23.9523.95-292.73-219.7919.23-25.62---
Operating Margin %-861.65-861.65-3,262.40-2,744.26-499.94-1,299.36-1,182.07-6,832.56-26,610.27
Net Margin %-848.69-848.69-3,274.60-2,638.52-491.51-1,299.84-1,717.56-6,979.70-26,400.34
Shares Outstanding million shares6.556.55+43.3%4.57+79.9%2.540.0%2.54+17.1%2.17+26.9%1.71+26.7%1.35+8.0%1.25
Market Capitalization3.143.14-74.5%12.30+61.2%7.63-17.0%9.19-23.2%11.96-78.9%56.57-11.6%63.96-

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q46/30/20262026Q33/31/20262026Q212/31/20252026Q19/30/20252025Q46/30/20252025Q33/31/20252025Q212/31/20242025Q19/30/2024
Total Revenue0.08+33.3%0.08+166.7%0.11+1000.0%0.09+800.0%0.06+100.0%0.030.0%0.01-75.0%0.01-83.3%
Cost of Goods Sold Incl. D&A0.08-20.0%0.07-30.0%0.07-36.4%0.06-50.0%0.10-16.7%0.10-16.7%0.11-21.4%0.12-20.0%
Gross Profit0.000.010.040.03-0.05-0.07-0.10-0.11
Selling, General and Administrative Excl. Other1.05+29.6%0.70+12.9%0.79-23.3%0.70-14.6%0.81-27.7%0.62-55.1%1.03+19.8%0.82-4.7%
Research and Development0.14+100.0%0.07-12.5%0.10-9.1%0.05+66.7%0.070.0%0.08-27.3%0.11-45.0%0.03-84.2%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.05-0.68-0.75-0.66-0.86-0.69-1.13-0.93
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.00-100.0%0.000.000.000.090.000.000.00
Net Income Before Taxes-1.04-0.68-0.73-0.64-0.92-0.66-1.12-0.91
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-1.04-0.68-0.73-0.64-0.92-0.66-1.12-0.91
Net Income From Continuing Operations-1.04-0.68-0.73-0.64-0.92-0.66-1.12-0.91
Net Income-1.04-0.68-0.73-0.64-0.92-0.66-1.12-0.91
EPS (Recurring) per share-0.18-0.15-0.16-0.14-0.19-0.16-0.40-0.34
EPS (Basic, Before Extraordinaries) per share-0.18-0.15-0.16-0.14-0.20-0.16-0.40-0.34
EPS (Diluted) per share-0.18-0.15-0.16-0.14-0.20-0.16-0.40-0.34
EBITDA-0.97-0.61-0.68-0.60-0.76-0.59-1.02-0.81
Non-Operating Income (Expense)0.01-50.0%0.01-50.0%0.010.0%0.020.0%0.02-33.3%0.02-50.0%0.01-80.0%0.02-66.7%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.05-80.8%0.070.07+75.0%0.070.0%0.26+271.4%-0.14-120.9%0.04+33.3%0.07+16.7%
Price To Sales Ratio ratio21.1924.8829.9372.07111.36118.88154.0357.78
Gross Margin %1.5814.3537.3135.90-83.08-227.50-785.07-951.33
Operating Margin %-1,329.55-820.90-689.73-702.18-1,538.19-2,240.87-8,862.61-8,243.06
Net Margin %-1,318.55-813.69-677.97-681.12-1,657.11-2,161.67-8,790.26-8,071.51
Shares Outstanding million shares6.55+43.3%4.74+3.7%4.57+63.8%4.57+63.8%4.57+79.9%4.57+79.9%2.79+9.8%2.79+9.8%
Market Capitalization3.14-74.5%8.41-13.0%8.64-34.8%13.95+123.9%12.30+61.2%9.67+70.5%13.26+131.8%6.23-4.0%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026FY6/30/20262025FY6/30/20252024FY6/30/20242023FY6/30/20232022FY6/30/20222021FY6/30/20212020FY6/30/20202019FY6/30/20192018FY6/30/2018
Cash & Short Term Investments2.30-1.3%2.33+7.4%2.17-59.5%5.36-25.1%7.16-33.1%10.71+161.9%4.09+305.0%1.01-76.3%4.27
Short Term Receivables0.010.0%0.01-66.7%0.03+200.0%0.010.0%0.01-80.0%0.05-16.7%0.060.00-100.0%0.01
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets0.10+11.1%0.09-77.5%0.40+263.6%0.11-80.4%0.56+86.7%0.30+30.4%0.23+130.0%0.10+100.0%0.05
Total Current Assets2.41-0.8%2.43-6.5%2.60-52.6%5.48-29.1%7.73-30.1%11.06+152.5%4.38+294.6%1.11-74.4%4.33
Net Property, Plant & Equipment0.02-50.0%0.04-33.3%0.06-33.3%0.090.0%0.09-10.0%0.10+100.0%0.05-44.4%0.09-10.0%0.10
Total Investments and Advances0.100.0%0.100.000.000.000.000.000.00-100.0%0.01
Intangible Assets0.50-3.8%0.52-18.8%0.64-17.9%0.78-27.1%1.07-18.3%1.31+2.3%1.28+32.0%0.97+870.0%0.10
Other Assets0.000.000.000.000.000.000.00-100.0%0.010.00
Total Assets3.03-2.3%3.10-6.3%3.31-47.9%6.35-28.5%8.88-28.8%12.48+118.9%5.70+161.5%2.18-51.9%4.53
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00-100.0%2.030.000.00
Accounts Payable0.05+66.7%0.03-40.0%0.05-28.6%0.07-41.7%0.12-14.3%0.14+27.3%0.11-47.6%0.21-
Other Current Liabilities0.330.0%0.33-56.0%0.75+275.0%0.20-68.3%0.63+5.0%0.60+5.3%0.57+375.0%0.12-52.0%0.25
Total Current Liabilities0.38+5.6%0.36-55.0%0.80+196.3%0.27-64.0%0.75+1.4%0.74-72.6%2.70+718.2%0.33+32.0%0.25
Long Term Debt0.000.000.000.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities--------0.00
Other Liabilities0.000.000.000.000.000.000.000.000.00
Total Liabilities0.38+5.6%0.36-55.0%0.80+196.3%0.27-64.0%0.75+1.4%0.74-72.6%2.70+718.2%0.33+32.0%0.25
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity2.65-3.3%2.74+8.7%2.52-58.6%6.08-25.3%8.14-30.7%11.74+291.3%3.00+63.0%1.84-57.0%4.28
Total Shareholders Equity2.65-3.3%2.74+8.7%2.52-58.6%6.08-25.3%8.14-30.7%11.74+291.3%3.00+63.0%1.84-57.0%4.28
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity2.65-3.3%2.74+8.7%2.52-58.6%6.08-25.3%8.14-30.7%11.74+291.3%3.00+63.0%1.84-57.0%4.28
Total Liabilities & Stockholders Equity3.03-2.3%3.10-6.3%3.31-47.9%6.35-28.5%8.88-28.8%12.48+118.9%5.70+161.5%2.18-51.9%4.53
Book Value Per Share per share0.41-31.7%0.60-39.4%0.99-58.6%2.39-36.4%3.76-45.1%6.85+208.6%2.22+51.0%1.47-62.5%3.92
Tangible Book Value Per Share per share0.33-31.2%0.48-35.1%0.74-64.6%2.09-35.9%3.26-46.4%6.08+378.7%1.27+84.1%0.69-82.0%3.83
Full-Time Employees people6-25.0%8-27.3%11-21.4%14-17.6%17-34.6%26+36.8%19-17.4%23+187.5%8
Price to Book Ratio ratio1.183.422.111.511.474.824.85--
Return on Assets %-101.06-112.84-91.13-54.53-84.83-127.45-105.84-117.43-
Return on Equity %-114.83-137.68-102.40-58.41-91.19-157.26-172.15-128.64-
Return on Invested Capital %-116.66-132.08-175.03-68.26-111.36-98.73-139.01-213.50-22.91
Quick Ratio ratio6.426.793.2620.6610.3314.921.623.3417.11
Current Ratio ratio6.426.793.2620.6610.3314.921.623.3417.11

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2026FY6/30/20262025FY6/30/20252024FY6/30/20242023FY6/30/20232022FY6/30/20222021FY6/30/20212020FY6/30/20202019FY6/30/2019
Net Income-3.10-3.10-3.62-4.40-4.15-9.06-11.59-4.17-3.94
Depreciation0.280.28-34.9%0.43-18.9%0.53-22.1%0.68-22.7%0.88+17.3%0.75+44.2%0.52+225.0%0.16
Other Funds (Non Cash)0.290.29+38.1%0.21-74.7%0.83+232.0%0.25-84.3%1.59-71.1%5.50+746.2%0.65-56.7%1.50
Funds from Operations-2.53-2.53-2.97-3.04-3.22-6.59-5.34-3.00-2.27
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital0.390.39-25.0%0.52+136.4%0.22-0.03-0.120.00-100.0%0.19+375.0%0.04
Cash from Operating Activities-2.15-2.15-2.46-2.81-3.25-6.72-5.33-2.81-2.23
Capital Expenditures-0.23-0.23-0.38-0.38-0.40-0.71-0.84-0.80-1.03
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.23-0.23-0.38-0.38-0.40-0.71-0.84-0.80-1.03
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock2.342.34-24.5%3.100.00-100.0%1.85-52.2%3.87-69.8%12.80+168.3%4.770.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock2.342.34-24.5%3.100.00-100.0%1.85-52.2%3.87-69.8%12.80+168.3%4.770.00
Proceedsfrom Stock Options2.342.34-24.5%3.100.00-100.0%1.85-52.2%3.87-69.8%12.80+168.3%4.770.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.00-100.0%1.920.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.00-0.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00-0.00
Cash from Financing Activities2.342.34-24.5%3.100.00-100.0%1.85-52.2%3.87-69.8%12.80+91.3%6.69-0.00
Net Change in Cash-0.03-0.03-111.5%0.26-3.19-1.79-3.56-153.8%6.62+114.9%3.08-3.27
Free Cash Flow-2.15-2.15-2.46-2.81-3.28-6.73-5.41-2.82-2.27
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q46/30/20262026Q33/31/20262026Q212/31/20252026Q19/30/20252025Q46/30/20252025Q33/31/20252025Q212/31/20242025Q19/30/2024
Cash & Short Term Investments2.30-1.3%0.64-78.4%1.17+88.7%1.83+19.6%2.33+7.4%2.96-0.3%0.62-83.1%1.53-67.0%
Short Term Receivables0.010.0%0.020.010.010.01-66.7%0.000.000.00-100.0%
Inventories0.000.000.000.000.000.000.000.00
Other Current Assets0.10+11.1%0.16-11.1%0.16-80.7%0.07-92.7%0.09-77.5%0.180.0%0.83+336.8%0.96+1100.0%
Total Current Assets2.41-0.8%0.82-73.9%1.33-8.3%1.91-23.6%2.43-6.5%3.14-0.3%1.45-62.4%2.50-47.1%
Net Property, Plant & Equipment0.02-50.0%0.02-60.0%0.03-40.0%0.03-50.0%0.04-33.3%0.05-28.6%0.05-37.5%0.06-25.0%
Total Investments and Advances0.100.0%0.100.100.100.100.000.000.00
Intangible Assets0.50-3.8%0.55-11.3%0.54-15.6%0.56-17.6%0.52-18.8%0.62+1.6%0.64+3.2%0.68-2.9%
Other Assets0.000.000.000.000.000.000.000.00
Total Assets3.03-2.3%1.49-60.9%2.00-6.5%2.60-19.8%3.10-6.3%3.81-0.5%2.14-53.0%3.24-41.2%
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.000.000.00
Accounts Payable0.05+66.7%0.02-33.3%0.02-85.7%0.02-66.7%0.03-40.0%0.03-50.0%0.14+133.3%0.06-25.0%
Other Current Liabilities0.330.0%0.17-5.6%0.46-37.8%0.41-48.1%0.33-56.0%0.18+20.0%0.74+572.7%0.79+338.9%
Total Current Liabilities0.38+5.6%0.19-9.5%0.49-44.9%0.43-48.8%0.36-55.0%0.210.0%0.89+394.4%0.84+223.1%
Long Term Debt0.000.000.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.000.000.00
Total Liabilities0.38+5.6%0.19-9.5%0.49-44.9%0.43-48.8%0.36-55.0%0.210.0%0.89+394.4%0.84+223.1%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity2.65-3.3%1.30-63.9%1.51+20.8%2.17-9.2%2.74+8.7%3.60-0.6%1.25-71.5%2.39-54.5%
Total Shareholders Equity2.65-3.3%1.30-63.9%1.51+20.8%2.17-9.2%2.74+8.7%3.60-0.6%1.25-71.5%2.39-54.5%
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity2.65-3.3%1.30-63.9%1.51+20.8%2.17-9.2%2.74+8.7%3.60-0.6%1.25-71.5%2.39-54.5%
Total Liabilities & Stockholders Equity3.03-2.3%1.49-60.9%2.00-6.5%2.60-19.8%3.10-6.3%3.81-0.5%2.14-53.0%3.24-41.2%
Book Value Per Share per share0.41-31.7%0.27-65.8%0.33-26.7%0.47-45.3%0.60-39.4%0.79-44.4%0.45-73.8%0.86-58.3%
Tangible Book Value Per Share per share0.33-31.2%0.16-75.4%0.21-4.5%0.35-42.6%0.48-35.1%0.65-44.9%0.22-85.1%0.61-65.9%
Full-Time Employees people6-25.0%---8-27.3%---
Price to Book Ratio ratio1.185.583.995.093.425.425.542.48
Return on Assets %-101.06-112.30-143.30-114.92-112.84-101.36-138.64-101.06
Return on Equity %-114.83-121.49-214.99-146.94-137.68-107.30-164.89-115.69
Return on Invested Capital %-39.30-52.06-48.57-29.62-33.74-18.44-89.91-37.94
Quick Ratio ratio6.424.332.724.466.7914.881.632.96
Current Ratio ratio6.424.332.724.466.7914.881.632.96

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q46/30/20262026Q33/31/20262026Q212/31/20252026Q19/30/20252025Q46/30/20252025Q33/31/20252025Q212/31/20242025Q19/30/2024
Net Income-1.04-0.68-0.73-0.64-0.92-0.66-1.12-0.91
Depreciation0.08-20.0%0.07-30.0%0.07-36.4%0.06-50.0%0.10-16.7%0.10-16.7%0.11-21.4%0.12-20.0%
Other Funds (Non Cash)0.06-62.5%0.080.070.07-91.1%0.16+128.6%-0.70-204.5%-0.02-166.7%0.79+1216.7%
Funds from Operations-0.90-0.53-0.59-0.51-0.67-1.27-1.03-0.00
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital0.24+4.3%0.08-86.4%-0.03-116.7%0.090.23-30.3%0.59+1080.0%0.18-0.48-2500.0%
Cash from Operating Activities-0.66-0.45-0.62-0.42-0.44-0.68-0.85-0.49
Capital Expenditures-0.02-0.08-0.04-0.09-0.09-0.08-0.06-0.15
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.02-0.08-0.04-0.09-0.09-0.08-0.06-0.15
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock2.340.00-100.0%0.000.000.003.100.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock2.340.00-100.0%0.000.000.003.100.000.00
Proceedsfrom Stock Options2.340.00-100.0%0.000.000.003.100.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities2.340.00-100.0%0.000.000.003.100.000.00
Net Change in Cash1.66-0.52-122.2%-0.66-0.50-0.532.34-0.92-0.64
Free Cash Flow-0.67-0.45-0.62-0.42-0.44-0.68-0.85-0.49

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20252026vs 20252026 share
Business B2 B0.080.30+256.7%81.6%
Individuals B2 C0.030.07+148.5%18.4%
Total0.110.36+230.2%100.0%
Region
Name20252026vs 20252026 share
United States0.110.36+230.2%100.0%
Total0.110.36+230.2%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.64%0.0M4.4M98.13K
2026-10-150.89%0.0M4.4M110.76K
2026-09-301.14%0.1M4.4M117.39K
2026-09-150.58%0.0M4.4M102.83K
2026-08-310.29%0.0M4.4M125.35K
2026-08-140.16%0.0M4.4M3.07M
2026-07-311.44%0.1M4.1M3.09M
2026-07-151.34%0.1M4.1M3.36M
2026-06-302.26%0.1M3.7M3.30M
2026-06-155.23%0.2M3.7M3.23M
2026-05-2918.93%0.6M3.1M3.26M
2026-05-1510.68%0.3M3.1M284.58K
2026-04-3010.00%0.3M3.3M273.40K
2026-04-153.34%0.1M3.0M33.31K
2026-03-313.27%0.1M3.2M34.72K
2026-03-132.00%0.1M3.2M196.53K
2026-02-273.62%0.1M3.2M191.01K
2026-02-134.30%0.1M3.2M191.92K
2026-01-303.41%0.1M3.2M182.35K
2026-01-153.13%0.1M3.2M191.31K

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-14ARSAnnual report to security holders. 2026-06-30SEC
2026-10-14DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-14DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-12-10SEC
2026-10-02PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-02SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-2310-KAnnual report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-09-178-KCurrent report2026-09-14SEC
2026-09-118-KCurrent report2026-09-11SEC
2026-07-30S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-07-208-KCurrent report2026-07-17SEC
2026-07-17424B5SEC
2026-07-138-KCurrent report2026-07-13SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-29SEC
2026-07-014Statement of changes in beneficial ownership of securities2025-05-22SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-03DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-06-03DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-07-13SEC
2026-05-28EFFECTEffectiveness filing by commission orderSEC
2026-05-26CORRESPSEC
2026-05-26S-1/ASEC
2026-05-198-KCurrent report2026-05-18SEC
2026-05-19UPLOADUpload SubmissionSEC
2026-05-1810-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-04-28SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-04600.00K200
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Focus Partners Wealth2.43%
GOLDMAN SACHS GROUP INC1.02%
VANGUARD CAPITAL MANAGEMENT LLC0.52%
STATE STREET CORP0.48%
GEODE CAPITAL MANAGEMENT, LLC0.44%
JANE STREET GROUP, LLC0.39%
VANGUARD FIDUCIARY TRUST CO0.24%
Warberg Asset Management LLC0.22%
RENAISSANCE TECHNOLOGIES LLC0.17%
OSAIC HOLDINGS, INC.0.15%

Funds

Fund% owned
VANGUARD EXTENDED MARKET INDEX FUND0.52%
Fidelity Extended Market Index Fund0.30%
Fidelity Series Total Market Index Fund0.07%
Fidelity Nasdaq Composite Index Fund0.04%
Dimensional U.S. Core Equity 2 ETF0.02%
Blackstone Alternative Multi-Strategy Fund0.00%

OakChart. AMST. Cached 15 minutes. Terms